BBC vs. NFLX

Last updated Jul 14, 2026

BBC (Virtus LifeSci Biotech Clinical Trials ETF) is Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while NFLX (Netflix, Inc.) is a stock. Over the past 10 years, BBC returned 11.19%/yr vs 22.33%/yr for NFLX. At a 0.34 correlation, their price movements are largely independent.

Performance

BBC vs. NFLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Netflix, Inc. (NFLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBC achieves a 33.14% return, which is significantly higher than NFLX's -21.26% return. Over the past 10 years, BBC has underperformed NFLX with an annualized return of 11.19%, while NFLX has yielded a comparatively higher 22.33% annualized return.

BBC

• 1D: -3.43%
• 1M: 19.31%
• 6M: 30.42%
• YTD: 33.14%
• 1Y: 146.38%
• 3Y*: 29.88%
• 5Y*: 2.74%
• 10Y*: 11.19%

NFLX

• 1D: 0.63%
• 1M: -8.10%
• 6M: -17.43%
• YTD: -21.26%
• 1Y: -40.70%
• 3Y*: 18.66%
• 5Y*: 6.14%
• 10Y*: 22.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. NFLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBC Virtus LifeSci Biotech Clinical Trials ETF	33.14%	63.77%	-1.11%	-1.80%	-35.13%	-22.31%	30.32%	63.81%	-18.29%	57.85%
NFLX Netflix, Inc.	-21.26%	5.19%	83.07%	65.11%	-51.05%	11.41%	67.11%	20.89%	39.44%	55.06%

Correlation

The correlation between BBC and NFLX is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.32
Correlation (10Y) Calculated over the trailing 10-year period	0.33
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014	0.34

The correlation between BBC and NFLX shifts across timeframes, from -0.01 (1 year) to 0.34 (all time), reflecting how their relationship changes across market environments.

Return for Risk

BBC vs. NFLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC

BBC Risk / Return Rank: 96
BBC Sharpe Ratio Rank: 98
BBC Sortino Ratio Rank: 96
BBC Omega Ratio Rank: 94
BBC Calmar Ratio Rank: 98
BBC Martin Ratio Rank: 96

NFLX

NFLX Risk / Return Rank: 4
NFLX Sharpe Ratio Rank: 3
NFLX Sortino Ratio Rank: 4
NFLX Omega Ratio Rank: 5
NFLX Calmar Ratio Rank: 6
NFLX Martin Ratio Rank: 4

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. NFLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Netflix, Inc. (NFLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BBC	NFLX	Difference
Sharpe ratio: Return per unit of total volatility	4.08	-1.19	+5.27
Sortino ratio: Return per unit of downside risk	4.42	-1.80	+6.21
Omega ratio: Gain probability vs. loss probability	1.53	0.78	+0.75
Calmar ratio: Return relative to maximum drawdown	9.75	-0.92	+10.67
Martin ratio: Return relative to average drawdown	28.51	-1.64	+30.15

BBC vs. NFLX - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 4.08, which is higher than the NFLX Sharpe Ratio of -1.19. The chart below compares the historical Sharpe Ratios of BBC and NFLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BBC vs. NFLX - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum NFLX drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for BBC and NFLX.

Drawdown Indicators

	BBC	NFLX	Difference
Max Drawdown Largest peak-to-trough decline	-76.85%	-81.99%	+5.14%
Max Drawdown (1Y) Largest decline over 1 year	-15.10%	-44.36%	+29.26%
Max Drawdown (3Y) Largest decline over 3 years	-54.45%	-47.06%	-7.39%
Max Drawdown (5Y) Largest decline over 5 years	-70.92%	-75.95%	+5.03%
Max Drawdown (10Y) Largest decline over 10 years	-76.85%	-75.95%	-0.90%
Current Drawdown Current decline from peak	-14.54%	-44.87%	+30.33%
Average Drawdown Average peak-to-trough decline	-36.97%	-24.97%	-12.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.16%	24.87%	-19.71%

Volatility

BBC vs. NFLX - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 10.38%, while Netflix, Inc. (NFLX) has a volatility of 11.86%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than NFLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBC	NFLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	11.86%	-1.48%
Volatility (6M) Calculated over the trailing 6-month period	26.30%	26.84%	-0.54%
Volatility (1Y) Calculated over the trailing 1-year period	36.18%	34.45%	+1.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.59%	43.38%	-3.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.70%	41.53%	-3.83%

Dividends

BBC vs. NFLX - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.28%, while NFLX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.28%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
NFLX Netflix, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BBC and NFLX in my portfolio?

BBC and NFLX have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBC or NFLX?

NFLX has higher volatility (11.86%) compared to BBC (10.38%). In terms of maximum drawdown, BBC dropped -76.85% vs NFLX's -81.99%.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (4.08 vs -1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.